Inhibition of EZH2 Ameliorates Lupus‐Like Disease in MRL/ <i>lpr</i> MiceDallas M. Rohraff(University of Michigan), Amr H. Sawalha(University of Pittsburgh)Arthritis & RheumatologyMay 20, 201910.1002/art.40931Cited by 63SaveCiteExport RISWatch citationsRelated PapersA disease-associated gene desert directs macrophage inflammation through ETS2|Nature|2024|139Identification of Cysteine‐Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in Scleroderma|Arthritis & Rheumatology|2019|24